News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No significant news items were published in the past hour.
  • No central bank statements or policy moves occurred during the hour.
  • No major corporate earnings, M&A, or credit events were reported.
  • No new geopolitical incidents or sanctions were announced in the past hour.
  • No market-moving economic data releases occurred in the hour.
  • Overall newsflow was light, leaving markets without fresh catalysts.

Latest Articles

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards

TTEC Holdings, Inc. has been awarded the Gold award in the 2026 Brandon Hall Group HCM Excellence Awards for their RealSkill AI-Driven Workforce Readiness program. The program uses AI-powered simulations and personalized coaching to help employees practice and improve customer interaction skills. This recognition highlights TTEC's leadership in app…

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Datacentrex, Inc. has secured colocation capacity for deployment of more than 500 prepaid ElphaPex DG2 Scrypt ASIC miners, expected to be energized within 30 days. This expansion will increase the company's aggregate hashrate by approximately 21%, improving fleet energy efficiency without additional capital expenditure. The deployment aligns with i…

NANO Nuclear and Tillman Digital Gateway Sign Strategic Commercial Framework to Enable Advanced Nuclear Power for Gigawatt-Scale U.S. AI Industrial Zones

NANO Nuclear and Tillman Digital Gateway Sign Strategic Commercial Framework to Enable Advanced Nuclear Power for Gigawatt-Scale U.S. AI Industrial Zones

NANO Nuclear Energy Inc. announced a strategic commercial framework agreement with Tillman Global Holdings to provide advanced nuclear reactor technology to power Tillman's planned gigawatt-scale AI industrial zones across the U.S. The companies aim to deploy 2 GW or more of advanced nuclear capacity by the mid-2030s and 6 GW or more by 2040, utili…

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma has engaged Synex Consulting Ltd. as the contract research organization to conduct Phase 1/2a clinical trials of its investigational CD19xCD22 bivalent CAR-T therapy (IBC101) targeting relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The engagement supports clinical trial execution in South Korea following regulatory a…

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Merlin, Inc., an aerospace and defense technology company specializing in autonomous flight systems, has received the Part 146 Aircraft Design Organization certificate from the Civil Aviation Authority of New Zealand. This certification authorizes Merlin's engineers to approve certain aircraft design changes internally, reducing reliance on externa…

Sika: A Content-Per-Project Compounder Riding the Construction Cycle

Sika: A Content-Per-Project Compounder Riding the Construction Cycle

Sika manufactures specialty chemicals and systems that increase the effective materials content per construction project. With steady end-market fundamentals, price and mix levers, and a track record of share gains, Sika sets up as a compounder inside a construction cycle. This trade idea outlines an actionable long entry, stop, and target, framed …

Crane NXT Announces Appointment of Jason Lund as President of Crane Payment Innovations and Group President of the Detection and Traceability Technologies Segment

Crane NXT Announces Appointment of Jason Lund as President of Crane Payment Innovations and Group President of the Detection and Traceability Technologies Segment

Crane NXT, a global industrial technology company, has appointed Jason Lund as President of Crane Payment Innovations and Group President of its Detection and Traceability Technologies segment. Lund brings extensive experience in leading industrial technology businesses and will focus on growth, operational excellence, and customer innovation withi…

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Arbutus Biopharma Corp. announced a modified Dutch auction tender offer to repurchase up to $230 million of its common shares, representing approximately 20.2% to 23.2% of outstanding shares. The offer price range is $5.00 to $5.75 per share, funded from cash on hand following a $178 million settlement payment from Moderna. The tender offer provide…

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

BridgeBio Pharma announced the presentation of new data on acoramidis, its oral transthyretin stabilizer for treating transthyretin amyloid cardiomyopathy (ATTR-CM), at the ESC Congress 2026. The data reinforce acoramidis as the first-line treatment choice, highlighting survival benefits, improved myocardial functions, and enhanced quality of life.…

Gogoro Inc. Announces Retirement of Chief Financial Officer and Appointment of Principal Financial Officer

Gogoro Inc. Announces Retirement of Chief Financial Officer and Appointment of Principal Financial Officer

Gogoro Inc., a leader in battery-swapping electric mobility and a Nasdaq-listed company, announced the retirement of its longtime Chief Financial Officer Bruce Aitken effective September 1, 2026. Jacky Lee, with extensive experience in finance and operations, has been appointed as the new Principal Financial Officer. Leadership expressed confidence…

Factory-Built Power: Why Bloom Energy's Modular Fuel Cells Are the Fastest Route to Scale for AI Data Centers

Factory-Built Power: Why Bloom Energy's Modular Fuel Cells Are the Fastest Route to Scale for AI Data Centers

Bloom Energy's factory-built solid oxide fuel cells have become a preferred quick-deploy power source for AI-heavy data centers. With Q2 revenue topping $1.065 billion and a $20 billion backlog, the company is converting scale and product innovation into revenue growth. The stock is richly valued, but the recent pullback and the rollout of Power Co…

Gemini and Apex Fintech Solutions Collaborate to Bring Gemini’s Regulated Crypto Prediction Markets to Apex's Distribution Network

Gemini and Apex Fintech Solutions Collaborate to Bring Gemini’s Regulated Crypto Prediction Markets to Apex's Distribution Network

Gemini and Apex Fintech Solutions have signed a letter of intent for Gemini to become the exclusive CFTC-regulated venue for crypto event contracts distributed through Apex's Futures Commission Merchant to its brokerage clients. This collaboration leverages Gemini’s regulatory milestones to enable brokering both crypto and potentially other event c…

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Monte Rosa Therapeutics has dosed the first patient in the MODeFIRe-1 Phase 2 clinical trial evaluating its investigational drug MRT-2359 combined with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer (mCRPC). This follows encouraging Phase 1/2 data showing promising clinical responses in this diffic…

Descartes Acquires Tai

Descartes Acquires Tai

Descartes Systems Group has acquired Tai, an AI-powered transportation management platform for freight brokers, for approximately $100 million. The acquisition enhances Descartes' transportation management offerings and expands its Global Logistics Network with advanced freight brokerage solutions. Tai’s platform automates freight operations and su…

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Rapport Therapeutics, a clinical-stage biotech company focused on neurological and psychiatric disorders, announced a virtual key opinion leader (KOL) event for September 22, 2026, to discuss the unmet needs in treating bipolar mania and the development of its lead investigational drug RAP-219. The event will feature expert insights on the limitati…